Refractory Pediatric AML
3 clinical trials · Condition
◉ Watch Refractory Pediatric AML
| Record | Firm | Date |
|---|---|---|
| Vyxeos® With Clofarabine for Pediatric AML (NCT07156435) | Princess Maxima Center for Pediatric Oncology | 2020-11-06 |
| Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy (NCT02638428) | Samsung Medical Center | 2015-12-01 |
Track Refractory Pediatric AML automatically
Every clearance here is in the API, with alerts when new ones post.